Concentrating on High-value Alzheimer's Needs to Get to an End Act of 2023
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™H.R. 4752, titled the Concentrating on High-value Alzheimer's Needs to Get to an End Act of 2023, is a health policy bill introduced in the 118th Congress. The bill was referred to the Subcommittee on Health but ultimately failed or expired without further legislative action. No official summary or full text is available, limiting detailed analysis. The bill appears to focus on addressing Alzheimer's disease, likely aiming to prioritize or concentrate efforts on high-value needs related to the condition.
H.R. 4752 sought to address Alzheimer's disease through targeted health initiatives but did not advance beyond subcommittee referral and expired without enactment.
- The bill is focused on health policy, specifically Alzheimer's disease.
- It was introduced in the House during the 118th Congress and referred to the Subcommittee on Health.
- No official summary or full text is publicly available, and the bill status is failed or expired.
["Individuals affected by Alzheimer's disease", "Healthcare providers and researchers specializing in Alzheimer's", 'Health agencies involved in disease research and treatment']
['Lack of publicly available full text and summary limits understanding of specific provisions and implementation requirements.', 'Without enacted status, no funding or authority changes were realized.', 'Potential challenges in oversight and enforcement cannot be assessed due to missing details.']
The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Health. It did not progress further and expired, indicating limited legislative momentum or prioritization within the congressional session. Alzheimer's disease remains a significant public health issue, and this bill represents one of several legislative efforts to address it.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
["If enacted, the bill could have influenced prioritization of Alzheimer's research funding and health services.", "Potential to affect coordination among health agencies focused on Alzheimer's disease.", "Could have raised public and legislative awareness about high-value needs in Alzheimer's care."]
The absence of an official summary and full bill text significantly limits transparency and public oversight. The bill's failure to advance past subcommittee referral suggests limited legislative engagement. Future efforts would benefit from ensuring full documentation and clear communication to stakeholders to facilitate informed debate and accountability.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.